氢溴酸达非那新置于sodium Hydroxide体系中,用 水 用作溶剂,化学反应生成达非那新 参考文献:Novel Polymorphs Of Darifenacin Free Base And Its Hydrobromide Salt 标题:Novel Polymorphs Of Darifenacin Free Base And Its Hydrobromide Salt 摘要:本发明提供了一种新颖且稳定的达瑞那新无水基固态非晶态形式,其制备方法,制药组合物和治疗方法.本发明还提供了一种新颖且稳定的达瑞那新盐酸盐多晶形式,其制备方法,制药组合物和治疗方法.
专利号:WO-2009153649-A1 优先权日:2008-06-19 标 题:Process for preparing 3-substituted pyrrolidine compounds 发明人:SOLDEVILLA MADRID NURIA 权利人:MEDICHEM SA; SOLDEVILLA MADRID NURIA 摘要:Disclosed is a process for preparing 3 -substituted pyrrolidine compounds of formula (VII) or salts thereof, wherein R1 is described herein, which are intermediate compounds useful for the synthesis of darifenacin which is indicated for the treatment of overactive bladder with symptoms of urge, urinary incontinence, and the like, and pharmaceutically acceptable salts thereof. Also disclosed is a process for preparing darifenacin and pharmaceutically acceptable salts thereof.
专利号:US-9982006-B2 优先权日:2014-08-21 标题:2′-chloro aminopyrimidinone and pyrimidine dione nucleosides 发明人:CLARKE MICHAEL O'NEIL HANRAHAN; MACKMAN RICHARD L; SIEGEL DUSTIN 权利人:GILEAD SCIENCES INC 摘要:Provided herein are formulations, methods and substituted 2′-chloro aminopyrimidinone and pyrimidine dione compounds of Formula (I) for treating Pneumovirinae virus infections, including respiratory syncytial virus infections, as well as methods and intermediates for synthesis of substituted 2′-chloro aminopyrimidinone and pyrimidine dione compounds.
专利号:EP-4630405-A1 优先权日:2022-12-06 标题 :Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
专利号:WO-2024123815-A1 优先权日:2022-12-06 标 题:Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels
专利号:US-2023271983-A1 优先权日:2020-07-29 标题 :Functionalized isonitriles and products, preparation and uses thereof 发明人:SOTELO PÉREZ EDDY; AZUAJE GUERRERO JHONNY ALBERTO; MAJELLARO MARIA 权利人:UNIV SANTIAGO COMPOSTELA 摘要:The present invention relates to functionalized isonitrile compounds, formed by means of multicomponent environmentally friendly reactions, suitable for coupling to functional molecules such as biomolecules, APIs, chromophore and fluorophore molecules. The invention also relates to conjugates between said isonitrile compounds and functional molecules, which are useful in the synthesis of pharmaceutic drugs or tools, fluorescent molecules and labels, polymeric smart materials. The invention furthermore provides a kit for the in-vitro preparation of the functionalized isontrile compounds and conjugates. The invention also contemplates the medical use of said compounds and conjugates.
专利号:CN-114126619-B 优先权日:2019-05-09 标 题:Compounds used in the synthesis of peptide mimetics
1: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Darifenacin. 2017 Jul 7. 45(4):325-50. doi: 10.2165/00003088-200645040-00001. 891:173707. doi: 10.1016/j.ejphar.2020.173707. Epub 2020 Oct 31. 21(13):885-92; discussion 893-4. doi: 10.2165/00002512-200421130-00005. 45(4):420-9; discussion 429. doi: 10.1016/j.eururo.2004.01.008. 33(4):475-82, viii. doi: 10.1016/j.ucl.2006.06.007. 41(7):441-52. doi: 10.1358/dot.2005.41.7.891719. 9: Parsons M, Robinson D, Cardozo L. Darifenacin in the treatment of overactive bladder. Int J Clin Pract. 2005 Jul;59(7):831-8. doi: 10.1111/j.1368-5031.2005.00585.x.
合成参考文献
参考文献:10.1016/j.urology.2009.12.013 摘要:Matsumoto Y, Miyazato M, Furuta A, Torimoto K, Hirao Y, Chancellor MB, Yoshimura N. Differential Roles of M2 and M3 Muscarinic Receptor Subtypes in Modulation of Bladder Afferent Activity in Rats. Urology. 2010 Apr;75(4):862–7. doi: 10.1016/j.urology.2009.12.013. 参考文献:10.1016/j.urology.2011.05.011 摘要:Yoshida A, Seki M, Nasrin S, Otsuka A, Ozono S, Takeda M, Masuyama K, Araki I, Ehlert FJ, Yamada S. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard. Urology. 2011 Sep;78(3):721.e7–721.e12. doi: 10.1016/j.urology.2011.05.011.